Search hospitals > Minnesota > Minneapolis
Fairview Southdale Hospital
Claim this profileMinneapolis, Minnesota 55435
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
555 reported clinical trials
15 medical researchers
Summary
Fairview Southdale Hospital is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Fairview Southdale Hospital is involved with conducting 555 clinical trials across 571 conditions. There are 15 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park7 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
97 reported clinical trials
159 drugs studied
Daniel M. AndersonRegions Hospital4 years of reported clinical research
Expert in Cancer
Expert in Tumors
60 reported clinical trials
108 drugs studied
Yan JiRegions Hospital1 year of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
74 drugs studied
Pamala A. PawloskiPark Nicollet Clinic - Saint Louis Park5 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
19 drugs studied
Clinical Trials running at Fairview Southdale Hospital
Breast Cancer
Cancer
Lung Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Gastric Cancer
Bladder Cancer
Multiple Myeloma
Esophageal Cancer
Anal Cancer
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fairview Southdale Hospital?
Fairview Southdale Hospital is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Fairview Southdale Hospital is involved with conducting 555 clinical trials across 571 conditions. There are 15 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.
Where is Fairview Southdale Hospital located?
**Directions to Fairview Southdale Hospital, Minneapolis:**
- Take Interstate 35W south to Highway 62 (Crosstown).
- Follow Highway 62 west to France Ave and turn left.
- Continue for one block to 65th St.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Fairview Southdale Hospital, visit [Fairview Financial Assistance](http://www.fairview.org/billing/fairview-financial-assistance) for policy details and application forms. For assistance or inquiries, contact the Customer Service Center at 612-672-6724. For insurance-related questions and bill payment options (online, by phone, by mail, or in person), refer to the Bill Pay & Financial Resources page.
What insurance does Fairview Southdale Hospital accept?
Fairview Southdale Hospital accepts a wide range of insurance plans, including the 2023 Fairview Medical Plans, which provide local coverage in the 11-county Twin Cities metro area and nationwide coverage. M Health Fairview providers are in-network for many insurance plans. UCare Individual & Family Plans with M Health Fairview feature cost-effective options with access to popular providers in the Twin Cities.
What awards or recognition has Fairview Southdale Hospital received?
Fairview Southdale Hospital, located in Minneapolis, Minnesota, is renowned for its emergency heart attack program and advanced imaging services. It has been named the top hospital in the Twin Cities metro for cardiology and coronary intervention. As part of the M Health Fairview system, it provides access to the University of Minnesota Medical Center's cutting-edge medical research and specialties.